Ptc Therapeutics(FRA) P91

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

N/A

Ptc Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$865.08

Net Income (TTM)

-$32.94

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

P91 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ptc Therapeutics

PTC Therapeutics, Inc. is a biopharmaceutical company. It engages in discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Industry

Biotechnology

Sector

Health Care

Employees

991

CEO

Matthew B. Klein, MD

Website

www.ptcbio.com

P91 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Ptc Therapeutics Performance Analysis

Ptc Therapeutics annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 664,907,780	45.9%
2023	2023-12-31	USD 867,457,650	30.5%
2024	2024-12-31	USD 745,850,878	-14.0%
2025	2025-12-31	USD 1,533,482,910	105.6%

Ptc Therapeutics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -7.42	17.9%
2023	2023-12-31	USD -7.74	4.4%
2024	2024-12-31	USD -4.37	-43.6%
2025	2025-12-31	USD 6.89	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$310.07

+2.0%

Gross Profit

$282.75

+2.0%

Gross Margin

91.19%

+1.0%

Market Cap

N/A

Market Cap/Employee

$5.94

N/A

Employees

991

N/A

Net Income

$71.81

-1.3%

EBITDA

$141.78

-5.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$1.53K

+27.6%

Total Debt

$609.17

+1.8%

Accounts Receivable

$209.08

+1.3%

Inventory

$79.90

+2.8%

Long Term Debt

$544.96

+1.7%

Short Term Debt

$64.21

+4.4%

Return on Assets

-1.30%

-0.0%

Return on Invested Capital

-145.91%

N/A

Free Cash Flow

$108.84

-1.0%

Operating Cash Flow

$110.73

-1.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

INTCIntel

INTCIntel$89.51+0.00%

NVDANvidia

NVDANvidia$220.78+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

SNAPSnap

SNAPSnap$5.55+0.02%

Questions About P91

What is the current price of Ptc Therapeutics?

Ptc Therapeutics is trading at N/A per share.

What is the 52-week range for Ptc Therapeutics?

Over the past 52 weeks, Ptc Therapeutics has traded between N/A and N/A.

How much debt does Ptc Therapeutics have?

As of the most recent reporting period, Ptc Therapeutics reported total debt of $609.17M.

How much cash does Ptc Therapeutics have on hand?

Ptc Therapeutics reported $918.30M in cash and cash equivalents in its most recent financial results.

What is Ptc Therapeutics’s dividend yield?

Ptc Therapeutics does not currently have a dividend yield.

Ptc Therapeutics(FRA) P91

Ptc Therapeutics Financials at a Glance

P91 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ptc Therapeutics

P91 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ptc Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About P91

What is the current price of Ptc Therapeutics?

What is the 52-week range for Ptc Therapeutics?

How much debt does Ptc Therapeutics have?

How much cash does Ptc Therapeutics have on hand?

What is Ptc Therapeutics’s dividend yield?

Premium Investing Services